[239] Neoadjuvant Treatment of Breast Carcinoma Does Not Affect the Accuracy of Intraoperative Sentinel Lymph Node Evaluation.

Hope T Richard, Dana L Johnson, Michael O Idowu, Celeste N Powers. Virginia Commonwealth University, Richmond

Background: The use of neoadjuvant therapy in breast carcinoma patients with tumors ≥ 2cm has increased significantly. The consequence of this treatment on the accuracy of intraoperative sentinel lymph node (SLN) evaluation is currently a subject of debate. This study evaluates the effects of neoadjuvant therapy on the intraoperative evaluation of SLN.
Design: We reviewed SLN from consecutive breast cancer patients between 1999 and 2010 with and without prior neoadjuvant therapy. The intraoperative diagnoses were then correlated with permanent section to determine the true positive (TP), true negative (TN), false negative (FN) and false positive (FP) rates. The proportion cases with positive lymph nodes on axillary dissection in the non-neoadjuvant (NNA) and neoadjuvant (NA) treated groups was then compared. Isolated tumor cells are included in micrometastasis. Statistical analysis was performed using the Chi square test.
Results: In this study 2169 SLN from 982 consecutive patients were reviewed. No significant difference was noted between the TP and FN rates of the NNA and NA groups (p=0.471). However, a significantly greater percentage of FN lymph nodes in the NA patients (3.5% vs. 1.8%) had metastases >2 mm noted on permanent section (p=0.00653). Additionally, a greater proportion of cases with SLN metastases >2mm had positive lymph nodes on completion axillary dissection as compared to those <2mm in both groups.

 True PositiveFalse Negative
 Macromets(>2mm)Micromets(<2mm)Macromets(>2mm)Micromets(<2mm)
No prior neoadjuvant (NNA) (n=1969 SLN)142(7%)25(1.3%)35(1.8%)73(3.7%)
Neoadjuvant (NA) (n=200 SLN)14(7%)6(3%)7(3.5%)7(3.5%)
p value0.471090.00653




 No prior neoadjuvant (n=224 cases)Neoadjuvant (n=23 cases)
 Macromets on SLN (>2mm)Micromets on SLN (<2mm)Macromets on SLN (>2mm)Micromets on SLN (<2mm)
Positive LN on axillary dissection104(46%)10(5%)13(57%)1(4%)
Negative LN on axillary dissection67(30%)43(19%)5(22%)4(17%)
p value0.34 (SLN >2mm in NA vs NNA and subsequent +axillary LN) & 0.95 (SLN <2mm in NA vs NNA and subsequent + axillary LN)



Conclusions: Overall, neoadjuvant therapy does not significantly affect the FN rate of intraoperative SLN evaluation. Furthermore, there is no significant difference in rate of positive LN on axillary dissection between non-neoadjuvant and neoadjuvant treated patients.
Category: Breast

Tuesday, March 1, 2011 11:30 AM

Platform Session: Section C, Tuesday Morning

 

Close Window